Bacteria of the Burkholderia cepacia complex (BCC) are associated with severe infection in cystic fibrosis. Recent evidence shows that the mucoid phenotype is common in BCC bacteria; however, during chronic infection, transitions from the mucoid to nonmucoid morphology have been shown to take place. Here we use RNA microarray and proteomic isobaric tagging relative and absolute quantitation technologies to gain insight into a pair of mucoid and nonmucoid isolates of B. cenocepacia obtained from a chronically infected patient with cystic fibrosis in the year prior to her death. During chronic infection, the mucoid isolate lost the B. cepacia epidemic strain marker and acquired a mutation in the cepR gene. In the nonmucoid isolate, we observed overexpression at both the RNA and protein level of several described putative virulence factors, including a nematocidal protein AidA and the oxidative stress response protein AhpC. We show that this translates into increased resistance to oxidative stress in the nonmucoid isolate, a key microbial determinant for resistance against phagocytic cell killing. These data illuminate the biological differences between mucoid and nonmucoid BCC bacteria, provide targets for elucidating the genetic control of exopolysaccharide production in the BCC, and highlight that chronic infection can produce both genetically and phenotypically distinct microbial variants in the cystic fibrosis lung.
Bacteria of the Burkholderia cepacia complex (BCC) are arguably the most clinically challenging pathogens involved in cystic fibrosis [1] . BCC infections are associated with a clinically unpredictable outcome-from slow decline in pulmonary function (as is characteristic of infection with Pseudomonas aeruginosa) to a rapidly fatal and uncontrollable septicemia known as cepacia syndrome [2] . The causes of these disparate outcomes are not known.
In P. aeruginosa infections in cystic fibrosis, the mucoid phenotype (as caused by overexpression of the exopolysaccharide alginate) is associated with advanced disease, and the exopolysaccharide is thought to interfere with normal host defenses [3] [4] [5] . The course of infection is well described, usually starting with a nonmucoid environmental isolate, which on chronic infection converts to the mucoid phenotype. Typically in chronic infections, P. aeruginosa also undergoes other phenotypic changes on the same genetic background; in particular, it loses virulence factors (such as motility, toxin production, and type III secretion) during chronic infection [6] [7] [8] . In contrast, there are few data on changes in phenotype and virulence of BCC bacteria on chronic infection during cystic fibrosis.
Exopolysaccharide production is common in clinical isolates of BCC bacteria, which produce at least 4 different types of exopolysaccharide, each of which is chemically distinct from alginate. The predominant exopolysaccharide appears to be cepacian (also known as PSII), and at least some genes involved in its biosynthesis are located within the bce cluster; the function of some has been elucidated [9] [10] [11] [12] . Two additional clusters, the wcb genes and a cluster on chromosome 2 (BCAM 1330-BCAM1340), are also possibly involved in the production of other exopolysaccharides [13, 14] . We recently demonstrated differential distribution of the mucoid phenotype among clinical isolates of the BCC; the more aggressive species, B. cenocepacia, is more frequently nonmucoid than other species of the complex [15] . Additionally, we noted, in longitudinally collected isolates from different patients infected with either B. cenocepacia or Burkholderia multivorans, that the phenotype switched from initial colonizing mucoid isolates to nonmucoid later in the course of infection. Although the capacity to produce exopolysaccharide is widespread in BCC bacteria, very little is known about the biology of exopolysaccharide production in terms of either its effect on the bacteria or its influence on the severity of infection in cystic fibrosis. In this study we have systematically evaluated the differences in gene and protein expression between a sequentially isolated (and isogenic) nonmucoid and mucoid pair from the same patient with cystic fibrosis [16] .
METHODS
Bacteria and culture conditions. Clinical isolates C8963 and C9343 were originally received in January 2000 and October 2000 and stored at Ϫ80ЊC in Mueller-Hinton broth and 8% dimethyl sulfoxide. Prior to these experiments, the bacteria were recovered from frozen culture at 37ЊC on blood agar plates (PML Microbiologicals); a single colony was purified and frozen again at Ϫ80ЊC to make a working freezer stock. Subsequently, the isolates were revived on blood agar at 37ЊC and then grown in Luria-Bertani (LB) broth (10 g/L tryptone, 5 g/L yeast extract, 10 g/L sodium chloride pH 7.1). For all experiments, overnight starter cultures (5.6 mL of LB broth in a 14-mL snap top tube incubated at 37ЊC) were adjusted to inoculate the equivalent of 1 mL of starter culture adjusted to an optical density value at 600 nm (OD 600 ) of 0.6 into 100 mL of LB broth in a 250 mL Erlenmeyer flask and incubated for 16 h at 37ЊC at 250 rpm in an orbital shaker. M9 minimal media agar was prepared [17] for oxidative stress experiments. Isolates were previously determined to be isogenic by genotyping using randomly amplified polymorphic DNA and pulsed field gel electrophoresis [16, 18] .
RNA isolation for transcriptomic studies. RNA was isolated using Ambion's RiboPure RNA extraction kit. Briefly for each culture flask, six 500 mL aliquots of each culture were harvested and snap chilled in an ethanol/dry ice bath. Aliquots were then pelleted at 4ЊC and RNA harvested according to the Ambion RiboPure RNA protocol, with DNAse treatment for 60 min at 37ЊC. RNA was extracted from 3 independent biological samples (3 separate cultures) for both isolates.
Microarrays. Microarray processing was performed by the CFFT program at the Mahenthiralingam Laboratory, Cardiff University, Wales. RNA was transcribed to complementary DNA using the CyScribe Post Labelling Kit (GE Healthcare), and complementary DNA was labeled using either Cy5 (C8963) or Cy3 (C9343). Transcriptome analysis was then performed using custom B. cenocepacia k v.2 arrays (Agilent). Full 4 ϫ 44 details of complementary DNA generation, mixing, hybridi- Microarray data analysis. Data from arrays included in this data set were imported into GeneSpring software (version 7.3.1), and the "Affymetrix FE" data normalization procedure was applied but without the "per gene" normalization step. At least 91% of probes on the 3 arrays were found to be present (data not shown). After normalization and exclusion of control genes and spike-in controls, differentially expressed genes were selected by filtering on flags (present in at least 1 of the samples), leaving 9512 of the original 10,073 genes. A t-test P value of !.05 was then applied with correction using the Benjamini-Hochberg false discovery rate, which left 1410. A 2-fold change filter was applied to identify differentially expressed genes.
Whole bacterial protein isolation for proteomic studies. Whole bacterial proteins were isolated from stationary phase cultures as described in Chung and Speert [19] and resuspended in buffer (5 mmol/L ethylenediaminetetraacetic acid in phosphate-buffered saline).
Isobaric tagging relative and absolute quantitation (iTRAQ) of proteomes. Whole bacterial protein extractions were prepared as described above and analyzed at the Genome BC Proteomics Centre as described in Kuzyk et al [20] . Samples were analyzed by reversed phase nanoflow (300 nL/min) high-performance liquid chromatography with nano-electrospray ionization using a quadrupole time-of-flight mass spectrometer (QStar pulsar i, Applied Biosystems) operated in positive ion mode.
iTRAQ data analysis. All data were analyzed using Protein Pilot software, version 2.0 (Applied Biosystems). Raw data files were searched against a database composed of amino acid sequences of putative proteins encoded by the B. cenocepacia J2315 genome (http://www.ncbi.nlm.nih.gov). Data from 2 separate iTRAQ experiments were analyzed; 95.5% and 82.8% of all spectra were assigned a peptide identification using this database, which represented a total of 937 and 1012 proteins that were initially identified in the 2 experiments. Proteins only identified by 1 unique peptide were excluded, reducing the number of identified proteins to 649 and 679, respectively. Of these, a core of 526 proteins were confidently identified in both. Protein and peptide identifications were then imported into an MS Access database to allow calculation of averages and standard deviations and integration of other data from the Burkholderia.com J2315 database [21] . We then used a 1.5-fold difference in expression between mucoid and nonmucoid isolates, a P value of !.05, and an error factor of !2 in the core data set as the criterion for differential expression. In addition, to qualify for inclusion, a protein must have been confidently identified as being underexpressed or overexpressed in 3 separate comparisons and therefore have been identified as such in both iTRAQ experiments.
Western blotting. AhpC protein was detected on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (PAGE) gels using immunoblotting with anti-Salmonella typhimurium AhpC antibody (a generous gift from G. Storz, National Institutes of Health, Maryland); this has previously been used successfully against Burkholderia pseudomallei [22] . Western blots were performed as described in Chung and Speert [19] using 15 mg of whole bacterial protein and a 1:4000 dilution of primary antibody.
Oxidative stress assays. Cultures of bacteria were incubated overnight and then adjusted to an OD 600 of 1.0. One hundred microliters of this culture were then spread on to M9 minimal media agar plates and allowed to dry. Six-millimeter filter discs impregnated with 15 mL of 5% cumene hydroperoxide were then added to the center of a lawn of bacteria and plates were incubated for 48 h before measurement.
RESULTS
To better understand the differences between mucoid and nonmucoid BCC bacteria and gain an insight into changes that can occur during chronic infection, we used transcriptomics and proteomics to systematically characterize our previously described nonmucoid C8963 and mucoid C9343 clinical cystic fibrosis isolates. We have previously described a scoring system for exopolysaccharide production from BCC bacteria, with isolates characterized as either nonmucoid and/or partially mucoid or else frankly mucoid [15] ; in this patient the first appearance of a nonmucoid and/or partially mucoid isolate was 3 years after the initial mucoid isolate. Isolates for this study were C9343 (mucoid) and C8963 (nonmucoid) and were recovered in the last year of the patient's life, representing an evolution of the initial infection with mucoid isolate (C3921) 10 years earlier (Table 1) ; these isolates are of particular interest because of the frank phenotypic differences between them, even on rich growth medium that does not normally enhance the mucoid phenotype.
Transcriptional Differences between a Nonmucoid and Mucoid Pair of Clinical Isolates
Transcriptomic analysis of stationary phase cultures of nonmucoid (C8963) and mucoid (C9343) B. cenocepacia identified 272 differentially expressed genes. Of these, 133 were overexpressed in C8963 and 139 were up-regulated in C9343 (Tables  2 and 3 ). Analysis of the predictions of the clusters of orthol- ogous groups (COGs) for overexpressed genes in nonmucoid B. cenocepacia showed there was no predominant category (Figure 1A) . In genes relatively overexpressed in mucoid B. cenocepacia ( Figure 1B) , however, there was distinct overrepresentation of genes with COG functions classified as transcription, amino acid transport and metabolism, carbohydrate transport and metabolism, and cell envelope biogenesis of the outer membrane. Transcriptional regulators and signal transduction mechanisms. The genetic mechanisms regulating the exopolysaccharide biosynthetic genes are unknown. Therefore, it is interesting that in the mucoid morphotype, a number of lysR type transcriptional regulator (LTTR) genes were significantly up-regulated, including 5 transcripts annotated as members of the LysR family of transcriptional regulators (BCAL1948, BCAL2452, BCAM2166, BCAM2751, and BCAS0370). In the B. cenocepacia strain J2315 genome, there are 223 orfs annotated as putative LTTRs, considerably more than the 121 in P. aeruginosa PAO1.
Other genetic regulators were also detected as overexpressed in nonmucoid C8963. First, there is differential regulation of the known N-acylhomoserine lactone (AHL) synthase genes, cepI and cciI. This is consistent with the previous observation of Conway et al [16] , that there is no AHL production detectable in the mucoid C9343. We have subsequently determined that there is a mutation in cepR in the mucoid C9343, which could explain the lack of detectable quorum sensing signaling molecules in this isolate (P. Sokol 2009, written communication). Another highly overexpressed regulator in nonmucoid C8963 is esmR, a putative negative transcriptional regulator [23] . Another highly overexpressed regulator in nonmucoid C8963 is esmR, a putative negative transcriptional regulator [23] . We have since determined that mucoid C9343 lacks a B. cepacia epidemic strain marker (BCESM) (as determined by polymerase chain reaction [23] ), indicating that this gene is either missing or disrupted (data not shown; preliminary data); it appears therefore that during chronic infection a mutational event occurred resulting in loss of some of the functions of genes encoded on the BCESM pathogenicity island.
Carbohydrate transport and metabolism and cell envelope biogenesis of the outer membrane. The mucoid phenotype is conferred by overproduction of exopolysaccharide, so we expected that a large number of genes related to carbohydrate transport and metabolism [20] , as well as cell envelope biogenesis of the outer membrane to be expressed [12] in the mucoid isolate. The overexpression of genes involved in sugar transport in the mucoid variant is consistent with an expected increased flux of sugar to produce the copious exopolysaccharide seen in C9343. However, the only members of the cepacian biosynthesis operon that were differentially regulated were bceF and bceG. Other polysaccharides are produced by C9343, so up-regulation of other genes encoding glycosyltrans-ferases (BCAM0206 and BCAM1008) presents possible regions to explain enhanced exopolysaccharide production.
Genes related to respiration and oxidative stress. Little is known about the aerobic respiratory apparatus of B. cenocepacia, in contrast to the well-described branched electron transport system in P. aeruginosa [24] . In the mucoid isolate there was overexpression of a putative cytochrome oxidase (BCAM2674 and BCAM2675), which by BLAST appears to be a cyanide insensitive oxidase (tblastn scores: 8EϪ148 and 1EϪ100, respectively, to cioAB in P. aeruginosa PAO1). There is also strong differential overexpression of genes involved in response to oxidative stress. Most notable among these genes was the strong up-regulation of ahpCF in the nonmucoid form. Additionally, overexpression of katB and a number of other oxidoreductases (BCAL0269 and BCAL1107) was observed in the mucoid morphotype, suggesting a differential requirement for oxidative stress responses in B. cenocepacia, associated with the exopolysaccharide phenotype.
Other genes. The most strongly differentially regulated gene in the data set was aidA, encoding a nematocidal protein [25] , which had a 1112-fold overexpression in the nonmucoid morphotype. In the inorganic ion transport category, there was strong up-regulation of a putative hemin ATP binding cassette (ABC) transport system in the mucoid morphotype, annotated as hmu in the J2315 sequence and also referred to as bhu (Burkholderia haem uptake) [26] . An additional ABC type transport system that is strongly overexpressed in the mucoid morphotype is that for putrescine (BCAL0595-BCAL598). Finally, the multidrug efflux system operon ceoABopcM was overexpressed in the mucoid morphotypes [27] .
iTRAQ Proteome-Wide Description
To gain a greater insight into the biological differences between the 2 isolates, we systematically examined differences between these 2 morphotypes at the protein level. Initially, we employed 2-dimensional (2-D) PAGE, identifying overexpression of AhpC and AhpF in the nonmucoid C8963 (data not shown). However, 2-D PAGE was highly time-consuming, expensive, and a difficult technique. We therefore employed a more robust system for proteome wide analysis, iTRAQ, for additional studies. iTRAQ permits not just the identification of proteins in a sample but also their relative quantities and does so in an objective manner not requiring manual examination of gels or expensive interpretation software [28] .
Data from 2 independent iTRAQ experiments (Table 4) , each containing 4 protein samples, identified a total of 26 proteins overexpressed in the mucoid C9343 and 23 proteins overexpressed in the nonmucoid C8963 (Table 5 ). The iTRAQ data validate the microarray study. First, 13 differentially expressed proteins identified in the iTRAQ experiments were also identified in the microarray study. Second, the relative differential levels of expression were generally consistent between the experiments; the more strongly differentially expressed proteins were associated with the higher magnitude of differential expression in the microarray.
Proteins highly expressed in mucoid B. cenocepacia. Of the proteins most highly expressed in mucoid B. cenocepacia, 7 of the 26 proteins are the products of genes also identified in the microarray experiment. The most overexpressed protein was a previously uncharacterized oxidoreductase (BCAL0269); its role in the mucoid phenotype is not clear. As with the data from the microarrays, it is perhaps not surprising that a number of proteins involved in energy production and metabolism are significantly overexpressed. The confirmation that CyaY, KatB, and MalE are also present as highly expressed proteins further validate their detection in the microarray study.
Proteins highly expressed in nonmucoid B. cenocepacia. Of the proteins most highly overexpressed in nonmucoid B. cenocepacia, a number of their genes were also previously detected in the microarray (6 of 23), similar to the proportion found in proteins most highly overexpressed in the mucoid B. cenocepacia. The relative magnitude of overexpression in the protein data was consistent, even if not identical, to the microarray data. Unlike the mucoid B. cenocepacia, which demonstrated overexpression of various proteins involved in metabolism, the proteome of nonmucoid B. cenocepacia was marked by high expression of a number of putative virulence factors. Most prominently, AidA [25] was seen as the most strongly overexpressed protein in the iTRAQ data, again validating its very high overexpression in the microarray data. AidA is essential for the slow killing of Caenorhabditis elegans. AhpC was also detected as strongly overexpressed and confirms the 2-D PAGE experiments and the microarrays. Finally, ZmpA, a putative virulence factor and quorum sensing controlled zinc metalloprotease [29, 30] , was also strongly overexpressed. Western blotting further confirmed overexpression in the nonmucoid morphotype of AhpC (Figure 2A ). This protein has been well described in other species [22, 31, 32] as acting enzymatically to reduce oxidative and nitrosative stress and shown to be up-regulated in a matte (phenotypically dry on agar plates) isolate of B. cenocepacia [19] . Because BCC bacteria are likely subject to a range of oxidative stresses in the lung, notably from massive neutrophil influx in cystic fibrosis, we determined whether the overexpression of AhpC endowed the nonmucoid morphotype with increased resistance to oxidative stress. Nonmucoid C8963 was more resistant to the effects of cumene hydroperoxide than was the mucoid C9343 on minimal medium ( ) ( Figure 2B ). This increase in resistance was al-P ! .001 so seen in another typical nonmucoid lab adapted isolate, K56-2.
DISCUSSION
To our knowledge, this study is the first transcriptome-wide and proteome-wide analysis of any pair of clinical isolates of B. cenocepacia, as well as the first description of the powerful proteome-wide analysis technique iTRAQ in Burkholderia species. By looking at clinical isolates of B. cenocepacia from the end stage of a chronic infection (Table 1) , we hoped to gain some insight into the biological properties of bacteria late in infection, as well as the biological differences between mucoid and nonmucoid BCC bacteria.
The transcriptomic study suggests that during chronic infection the mucoid isolate had acquired not only a mutation in the quorum sensing regulator cepR but also in the BCESM (Table 2 ; preliminary data). Such mutations are the likely explanations for the up-regulation of many virulence factors seen in the nonmucoid isolate, because the BCESM also contains a second quorum sensing system-thecciI/R system. Given the well-described genomic plasticity of BCC bacteria [33] [34] [35] , it is not surprising that during the course of chronic infection the bacteria can accumulate mutations. What is particularly interesting is that they should be in global regulators of welldescribed virulence factors. This observation is consistent with the established paradigm in P. aeruginosa infections, where there is a gradual loss of virulence. The loss of the BCESM, in particular, in the final 2 isolates from this patient is a point that merits additional investigation because it has not been previously reported in BCC bacteria. It appears that chronic infection may select for loss of this genomic region, and additional work is needed to understand its significance. Identification of highly expressed LysR-type transcriptional regulators in the mucoid isolate also yielded potential targets for understanding the genetic regulation of exopolysaccharide production.
Transcriptomics can only inform us of the differential regulation of messenger RNA, which does not necessarily translate into biological significance resulting from posttranslational events. iTRAQ, on the other hand, not only identifies proteins that are present in a biological sample but also identifies differential production. In this study this technique identified over 500 proteins, of which just 49 were differentially regulated (Table 6). Proteomic analysis of the mucoid and/or nonmucoid pair revealed that there are minimal differences in stationary phase protein complement of whole bacterial proteins in these bacteria. The iTRAQ data did, however, show that most proteins that were detected as differentially expressed did not display a detectable difference in the transcriptome. Therefore, these approaches are complementary, because iTRAQ data yielded identifications that would have been missed by a purely transcriptomic analysis.
Cystic fibrosis infections are marked by cycles of inflammation and a massive influx of neutrophils to the sites of infection [36] . BCC bacteria are highly resistant to cationic peptides and nonoxidative killing; therefore, exposure to oxidative stress, produced by the respiratory burst from white blood cells such as neutrophils, is likely to be a key host defense against these bacteria [36] . We have previously shown that the exopolysaccharide produced by C9343 scavenges reactive oxygen species, potentially forming a protective barrier [37] . Thus, overexpression of AhpC in the nonmucoid isolate at the transcript and protein and functional levels suggests that it could act as a compensatory mechanism for the loss of the reactive oxygen species quenching exopolysaccharide.
These data provide new insights into the role played by microbial phenotypic conversion in adaptation of bacteria from the BCC and at first consideration appear to be in contrast with P. aeruginosa, where conversion to the mucoid phenotype is associated with adverse clinical outcome [38] and coincidentally diminished expression of virulence determinants. Indeed, we have recently found, in a retrospective analysis of patients with cystic fibrosis in Vancouver, that infection with the mucoid phenotype was associated with a significantly better clinical outcome than infection with nonmucoid bacteria (Zlosnick et al 2010, unpublished data).
Infections by BCC bacteria are marked by unpredictable outcome, including the potential for invasion from the lungs, a feature never seen with P. aeruginosa; differential pathogenic mechanisms are therefore likely engaged by the 2 groups of pathogens. In BCC bacteria, the mucoid phenotype appears to confer properties that favor survival, either in the natural environment (probably soil) or in the incidental compromised human host (patients with cystic fibrosis). Conversion to the nonmucoid phenotype may endow the bacteria with a higher degree of virulence and favor invasive disease, as is seen in the cepacia syndrome. Additional investigation of the specific putative virulence determinants identified in these studies should add substantially to our understanding of the pathobiology of this evolving human opportunistic pathogen.
